Elevance Health (ELV) Market Capitalization (2009 - 2026)

Elevance Health (ELV) has reported Market Capitalization for 18 consecutive years, with $83.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 4.11% year-over-year to $83.9 billion in Q2 2026; TTM through Jun 2026 was $83.9 billion, a 4.11% decrease from a year earlier, with the FY2025 full-year figure at $77.4 billion, down 7.8% from the prior year.
• Market Capitalization was $83.9 billion for Q2 2026 at Elevance Health, up from $63.6 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $125.7 billion in Q2 2024 and troughed at $63.6 billion in Q1 2026.
• A 5-year average of $101.3 billion and a median of $106.7 billion in 2022 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization jumped 34.47% in 2022 and plunged 40.51% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $122.1 billion in 2022, then dropped by 9.96% to $109.9 billion in 2023, then dropped by 23.65% to $83.9 billion in 2024, then fell by 7.8% to $77.4 billion in 2025, then increased by 8.38% to $83.9 billion in 2026.
• The last three Market Capitalization figures came in at $83.9 billion (Q2 2026), $63.6 billion (Q1 2026), and $77.4 billion (Q4 2025), per Business Quant data.